We are Sorry, This Page doesn't Exist
Merck announces FDA approval of Keytruda for certain bladder cancer patients
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Roche announces FDA approval of Tecentriq with chemotherapy for lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Qiagen receives FDA approval to expand use of EGFR test in lung cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Zai Lab announces approval of Zejula for patients with relapsed ovarian cancer
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Qiagen gets Japan approval for EGFR lung cancer test as companion diagnostic
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
FDA Approves Novartis" Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine Tumors
Discover Novartis' FDA approval for Lutathera in pediatric patients with GEP-NETs, marking a pivotal milestone in treating this rare cancer. Explore its efficacy in combating SSTR+ tumors, backed by robust trial data. read more.....»»
NovoCure surges 65% to all-time high on upbeat review of its lung cancer treatment trial
"Pending regulatory approval, the recommended protocol adjustments could accelerate trial completion by more than a year," its CEO said. In this phot.....»»
Cancer Genetics announces shareholder approval of proposals for StemoniX merger
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
G1 Therapeutics" Trilaciclib Wins FDA Nod For Mitigating Chemo Effects In Lung Cancer Patients
read more.....»»
Eli Lilly, Innovent Biologics" Sintilimab Injection Receives China Approval For A Type Of Lung Cancer
read more.....»»
Biodesix begins biomarker study of Nodify XL2 lung cancer test
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Mount Sinai gets rare FDA approval for antibody testing
The Mount Sinai Laboratory is one of only a handful of labs to receive emergency authorization from the Food and Drug Administration to test whether patients have the antibodies to fight off the... To view the full story, click the title link......»»
AstraZeneca to test blood-cancer drug for severely ill COVID-19 patients
Shares of AstraZeneca were up 0.6% in trading on Tuesday; this morning the .....»»
Veracyte announces publication of study using Prosigna breast cancer test
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Watch: Rush Limbaugh Announces Advanced Lung Cancer Diagnosis
Listen: Rush Limbaugh Announces Advanced Lung Cancer Diagnosis Conservative radio icon Rush Limbaugh announced on his Monday show that he has been diagnosed with advanced lung cancer. Limbaugh fir.....»»
Rush Limbaugh announces he"s been diagnosed with advanced lung cancer
AP Photo/Julie Smith, File Talk radio host Rush Limbaugh announced during his show on Monday that he .....»»
Listen: Rush Limbaugh Announces Advanced Lung Cancer Diagnosis
Listen: Rush Limbaugh Announces Advanced Lung Cancer Diagnosis Conservative radio icon Rush Limbaugh announced on.....»»
The Daily Biotech Pulse: Xeris Jumps On Positive Data, Mixed Results For Merck"s Keytruda-Chemo Combo In Lung Cancer, Intra-Cellular Announces Offering
The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biot.....»»
AstraZeneca’s FDA Nod Could Be Big
AstraZeneca has announced that the FDA has approved its companion diagnostic test that identifies patients with metastatic pancreatic cancer......»»